Cargando…
14-3-3 phosphorylation inhibits 14-3-3θ’s ability to regulate LRRK2 kinase activity
LRRK2 mutations are among the most common genetic causes for Parkinson’s disease (PD), and toxicity is associated with increased kinase activity. 14-3-3 proteins are key interactors that regulate LRRK2 kinase activity. Phosphorylation of the 14-3-3θ isoform at S232 is dramatically increased in human...
Autores principales: | Pattanayak, Rudradip, Petit, Chad M., Yacoubian, Talene A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10312468/ https://www.ncbi.nlm.nih.gov/pubmed/37398189 http://dx.doi.org/10.1101/2023.05.27.542591 |
Ejemplares similares
-
14-3-3θ Does Not Protect against Behavioral or Pathological Deficits in Alzheimer’s Disease Mouse Models
por: Gannon, Mary, et al.
Publicado: (2022) -
14-3-3theta Protects against Neurotoxicity in a Cellular Parkinson's Disease Model through Inhibition of the Apoptotic Factor Bax
por: Slone, Sunny R., et al.
Publicado: (2011) -
Dysregulation of 14‐3‐3 proteins in neurodegenerative diseases with Lewy body or Alzheimer pathology
por: McFerrin, Michael B., et al.
Publicado: (2017) -
PAK6 Phosphorylates 14-3-3γ to Regulate Steady State Phosphorylation of LRRK2
por: Civiero, Laura, et al.
Publicado: (2017) -
14-3-3 mitigates alpha-synuclein aggregation and toxicity in the in vivo preformed fibril model
por: Underwood, Rachel, et al.
Publicado: (2021)